Prognostic value of the neutrophil to lymphocyte ratio in the clinical course of liver cirrhosis

Author:

Sarkarova M. R.1,Maevskaya M. V.2

Affiliation:

1. Sechenov First Moscow State Medical University (Sechenov University); Dagestan State Medical University

2. Sechenov First Moscow State Medical University (Sechenov University)

Abstract

Introduction. The search for simple and informative markers for predicting positive outcomes in patients with liver cirrhosis (LC) does not affect its relevance.Aim. To study the possibility of using the “neutrophil to lymphocyte ratio” indicator as a predictor of development of LC complications and death.Materials and methods. For a retrospective clinical study, 225 case histories of patients with LC were selected from 2008 to 2018. Three groups were formed from them: group 1: patients with LC class A according to Child- Pugh (24n); Group 2: patients with LC class B and C according to Child- Pugh (201n); and group 3: healthy individuals (50n). A correlation analysis of the NLR indicator with the Child- Pugh and MELD scales was carried out. The prognostic value of NLR in the development of complications and death was analyzed.Results. Patients with LC had statistically significantly higher values of NLR compared to healthy individuals (p < 0.001). NLR had a statistically significant positive correlation with the Child- Pugh (p < 0.001) and MELD (p < 0.001) scales. NLR is a statistically significant predictor of the development of complications in patients with LC (p = 0.003). A NLR value > 2.3 had a sensitivity of 0.97 [95% CI: 0.92; 0.99] and specificity 0.19 [95% CI: 0.11; 0.29]. NLR statistically significantly correlated with the number of complications of LC (p<0.001) and served as a statistically significant predictor of death (p<0.001). A NLR value > 4.5 had a sensitivity of 0.24 [95% CI: 0.15; 0.36] and specificity 0.97 [95% CI: 0.92; 0.99].Conclusion. An NLR value of more than 2.3 increases the risk of complications in patients with LC, and an NLR value of more than 4.5 increases the risk of death.

Publisher

Remedium, Ltd.

Reference47 articles.

1. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–231. https://doi.org/10.1016/j.jhep.2005.10.013.

2. Xazanov AI, Nekrasova NN. Improvement of the Child-Puhg system to improve the accuracy of liver cirrhosis prognosis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2002;12(2):16–20. (In Russ.) Available at: http://elib.fesmu.ru/Article.aspx?id=89506.

3. Ивашкин ВТ, Федосьина ЕА, Денежкина НВ (ред.). Резистентный асцит у больных с циррозом печени. М.: МедПресс-Информ; 2013. 80 с.

4. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P еt al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310–1324. https://doi.org/10.1016/j.jhep.2014.01.024.

5. Piano S, Tonon M, Angeli P. Changes in the epidemiology and management of bacterial infections in cirrhosis. Clin Mol Hepatol. 2021;27(3):437–445. https://doi.org/10.3350/cmh.2020.0329.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3